logo

PRME

Prime Medicine·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
4.66 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is PRME a Buy, Sell, or Hold?
  • Based on a composite score of 4.66/10, we rate PRME as a Netural. Our analysis breaks down into 3.39/10 for Fundamentals, 5.57/10 for Technicals, and 4.85/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is PRME fundamentally strong?
What is the current technical signals for PRME?
What is the analyst consensus for PRME?